| 1 |
Rowley AH. Is Kawasaki disease an infectious disorder? Int J Rheum Dis 2018;21:20-5.
DOI
|
| 2 |
Benseler SM, McCrindle BW, Silverman ED, Tyrrell PN, Wong J, Yeung RS. Infections and Kawasaki disease: implications for coronary artery outcome. Pediatrics 2005;116:e760-6.
DOI
|
| 3 |
Rowley AH, Shulman ST. The epidemiology and pathogenesis of Kawasaki disease. Front Pediatr 2018;6:374.
DOI
|
| 4 |
McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 2017;135:927-99.
|
| 5 |
Cox F, Foshee W, Miller J Jr, Moore S. Simultaneous Kawasaki disease and group A streptococcal pharyngitis. Clin Pediatr (Phila) 1993;32:48-50.
DOI
|
| 6 |
Matsubara K, Fukaya T. The role of superantigens of group A Streptococcus and Staphylococcus aureus in Kawasaki disease. Curr Opinion Infect Dis 2007;20:298-303.
DOI
|
| 7 |
Morita A, Imada Y, Igarashi H, Yutsudo T. Serologic evidence that streptococcal superantigens are not involved in the pathogenesis of Kawasaki disease. Microbiol Immunol 1997;41:895-900.
DOI
|
| 8 |
Min DE, Kim DH, Han MY, Cha SH, Yoon KL. High antistreptolysin O titer is associated with coronary artery lesions in patients with Kawasaki disease. Korean J Pediatr 2018 Nov 7 [Epub]. https://doi.org/10.3345/kjp.2018.06989.
|
| 9 |
Rowley AH, Baker SC, Shulman ST, Garcia FL, Fox LM, Kos IM, et al. RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease. PLoS One 2008;3:e1582.
DOI
|
webmaster
